Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 231.00
+0.60 (0.26%)
Sep 19, 2025, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 18.07 billion as of September 19, 2025. Its market cap has decreased by -10.34% in one year.
Market Cap
18.07B
Enterprise Value
16.55B
Revenue
6.46B
Ranking
n/a
PE Ratio
12.86
Stock Price
231.00
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 18.07B, an increase of 42,214.32%. That is a compound annual growth rate of 25.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 18.07B | 21.49% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | 10.91B | 96.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,726.72B |
| Coloplast | 133.39B |
| Genmab | 111.26B |
| Demant | 50.70B |
| ALK-Abelló | 46.85B |
| H. Lundbeck | 42.83B |
| Zealand Pharma | 32.91B |
| Ambu A/S | 26.23B |